196 related articles for article (PubMed ID: 37311281)
21. Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer.
Azari M; Bahreini F; Uversky VN; Rezaei N
Biochem Pharmacol; 2023 Apr; 210():115459. PubMed ID: 36813121
[TBL] [Abstract][Full Text] [Related]
22. Design of Bioengineered Peptides/Proteases as Anti-cancer Reagents with Integrated Omics and Machine Learning Approaches.
Zuo W; Kwok HF
Methods Mol Biol; 2024; 2747():295-309. PubMed ID: 38038948
[TBL] [Abstract][Full Text] [Related]
23. A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.
Naeem M; Iqbal MO; Khan H; Ahmed MM; Farooq M; Aadil MM; Jamaludin MI; Hazafa A; Tsai WC
Molecules; 2022 May; 27(11):. PubMed ID: 35684353
[TBL] [Abstract][Full Text] [Related]
24. Cyclic Peptides for the Treatment of Cancers: A Review.
Ramadhani D; Maharani R; Gazzali AM; Muchtaridi M
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889301
[TBL] [Abstract][Full Text] [Related]
25. Preclinical Evidence on the Anticancer Properties of Food Peptides.
Rajendran SR; Ejike CE; Gong M; Hannah W; Udenigwe CC
Protein Pept Lett; 2017; 24(2):126-136. PubMed ID: 27538700
[TBL] [Abstract][Full Text] [Related]
26. New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.
Caponigro F; Basile M; de Rosa V; Normanno N
Anticancer Drugs; 2005 Feb; 16(2):211-21. PubMed ID: 15655420
[TBL] [Abstract][Full Text] [Related]
27. Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs.
Lath A; Santal AR; Kaur N; Kumari P; Singh NP
Biotechnol Genet Eng Rev; 2023 Apr; 39(1):45-84. PubMed ID: 35699384
[TBL] [Abstract][Full Text] [Related]
28. Membrane disrupting lytic peptides for cancer treatments.
Leuschner C; Hansel W
Curr Pharm Des; 2004; 10(19):2299-310. PubMed ID: 15279610
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Potential of Natural Compounds in Lung Cancer.
Al-Yozbaki M; Wilkin PJ; Gupta GK; Wilson CM
Curr Med Chem; 2021; 28(39):7988-8002. PubMed ID: 33749551
[TBL] [Abstract][Full Text] [Related]
30. New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology.
Balducci L; Falandry C; List A
Curr Oncol Rep; 2022 Dec; 24(12):1695-1703. PubMed ID: 35986858
[TBL] [Abstract][Full Text] [Related]
31. Evolving strategies and application of proteins and peptide therapeutics in cancer treatment.
Mukherjee AG; Wanjari UR; Gopalakrishnan AV; Bradu P; Biswas A; Ganesan R; Renu K; Dey A; Vellingiri B; El Allali A; Alsamman AM; Zayed H; George Priya Doss C
Biomed Pharmacother; 2023 Jul; 163():114832. PubMed ID: 37150032
[TBL] [Abstract][Full Text] [Related]
32. Use of anticancer peptides as an alternative approach for targeted therapy in breast cancer: a review.
Orafaie A; Bahrami AR; Matin MM
Nanomedicine (Lond); 2021 Feb; 16(5):415-433. PubMed ID: 33615876
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743
[TBL] [Abstract][Full Text] [Related]
34. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Huang Y; Feng Q; Yan Q; Hao X; Chen Y
Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
[TBL] [Abstract][Full Text] [Related]
35. Clinical applications of nanomedicines in lung cancer treatment.
Norouzi M; Hardy P
Acta Biomater; 2021 Feb; 121():134-142. PubMed ID: 33301981
[TBL] [Abstract][Full Text] [Related]
36. DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer.
Jiang Y; Huang W; Sun X; Yang X; Wu Y; Shi J; Zheng J; Fan S; Liu J; Wang J; Liang Z; Yang N; Liu Z; Liu Y
J Hematol Oncol; 2022 Jun; 15(1):73. PubMed ID: 35659720
[TBL] [Abstract][Full Text] [Related]
37. Emerging therapeutic agents for lung cancer.
Dholaria B; Hammond W; Shreders A; Lou Y
J Hematol Oncol; 2016 Dec; 9(1):138. PubMed ID: 27938382
[TBL] [Abstract][Full Text] [Related]
38. Peptide-based cancer therapy: opportunity and challenge.
Wu D; Gao Y; Qi Y; Chen L; Ma Y; Li Y
Cancer Lett; 2014 Aug; 351(1):13-22. PubMed ID: 24836189
[TBL] [Abstract][Full Text] [Related]
39. Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer.
Karuppasamy R; Veerappapillai S; Maiti S; Shin WH; Kihara D
Semin Cancer Biol; 2021 Jan; 68():84-91. PubMed ID: 31698087
[TBL] [Abstract][Full Text] [Related]
40. Peptide-Based Therapeutics for Oncology.
Fisher E; Pavlenko K; Vlasov A; Ramenskaya G
Pharmaceut Med; 2019 Feb; 33(1):9-20. PubMed ID: 31933267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
